Matches 1 - 39 out of 39


Match Document Document Title
US20110223195 COMPOSITION COMPRISING CHITOSAN FOR OCULAR ADMINISTRATION OF VACCINE(S) TO AVIANS  
The invention relates to vaccine compositions comprising chitosan and a vaccine which are administered to avian species via the ocular route, and methods or programs of vaccination including use...
US20110150933 CATTLE VACCINES  
This document provides live non-pathogenic M. bovis bacteria and compositions containing live non-pathogenic M. bovis bacteria. This document also provides methods of using live non-pathogenic M....
US20130302373 ATTENUATED MYCOPLASMA GALLISEPTICUM STRAINS  
The present invention provides live, attenuated Mycoplasma gallisepticum bacteria that exhibit reduced expression of a protein identified as MGA_0621. In certain embodiments, the attenuated...
US20110129494 Vaccine Formulations Comprising Saponin-containing Adjuvants  
The present invention provides for a novel oil-in-water (O/W) emulsion, with increased stability in the presence of bacterial or viral suspensions, especially those concentrated and non-purified...
US20120135040 TEMPERATURE SENSITIVE VACCINE STRAIN OF MYCOPLASMA HYOPNEUMONIAE AND USES THEREOF  
The present invention relates to a Mycoplasma hyopneumoniae vaccine strain comprising a mutation in at least one of the genes listed or as deposited with the National Measurements Institute...
US20130243819 Methods Relating To An Attenuated Mycoplasma  
The present invention provides a method for identifying or generating an attenuated mycoplasma bacterium, which bacterium comprises a mutation in at least one gene as listed and use of the...
US20150086587 VACCINE ADJUVANT  
Oil-based adjuvant emulsions, immunogenic compositions, and methods of using the same to elicit immunological responses in a subject are provided. The oil-based adjuvants comprise a plant-derived...
US20150086590 LPS VACCINE  
A vaccine composition for birds comprising as an active ingredient a structure containing O-antigen derived from Gram-negative bacteria, provided that said structure does not contain a whole cell,...
US20110059128 VACCINE COMPOSITION FOR VACCINATING DOGS AGAINST CANINE INFECTIOUS RESPIRATORY DISEASE (CIRD)  
A vaccine composition for vaccinating dogs comprising any one or more of (a) an agent capable of raising an immune response against Streptococcus equi sub species zooepidemicus in a dog, (b) an...
US20140370058 ONE DOSE VACCINATION AGAINST MYCOPLASMA INFECTIONS OF PIGS  
The present invention provides a one phase, aqueous vaccine composition for immunizing an animal against infection by Mycoplasma hyopneumoniae, comprising: an immunizing amount of a Mycoplasma...
US20130230558 ONE DOSE VACCINATION AGAINST MYCOPLASMA INFECTIONS OF PIGS  
The present invention provides a one phase, aqueous vaccine composition for immunizing an animal against infection by Mycoplasma hyopneumoniae, comprising: an immunizing amount of a Mycoplasma...
US20120021005 MYCOPLASMA GALLISEPTICUM FORMULATION  
The present invention provides a formulation that prevents virulent Mycoplasma galHsepticum infection in birds of the order GaIHf ormes. The formulation comprises live Mycoplasma galHsepticum...
US20100272759 MODIFIED LIVE VACCINE OF MYCOPLASMA BOVIS, METHODS OF PRODUCING MODIFIED LIVE MYCOPLASMA BOVIS VACCINES, COMBINATION VACCINES AND METHODS OF TREATMENT  
The present invention relates to new attenuated M. bovis bacteria strains passaged at least 110 times. Moreover, the present invention also provides immunogenic compositions comprising live...
US20120213816 MYCOPLASMA HYOPNEUMONIAE BACTERIN VACCINE  
The invention provides an improved Mycoplasma hyopneumoniae bacterin vaccine composition, which advantageously provides immunity from infection after a single administration. The composition...
US20140056940 NOVEL ADJUVANT COMPOSITIONS  
This invention relates to adjuvant formulations comprising various combinations of triterpenoids, sterols, immunomodulators, polymers, and Th2 stimulators; methods for making the adjuvant...
US20100266629 Cattle Reproductive Disease Vaccines  
The present invention relates to combination vaccines and methods for treating or preventing diseases or disorders in an animal caused by infection by Bovine Viral Diarrhea Virus (BVDV) Types 1...
US20130266601 Mycoplasma Hyopneumoniae Vaccine  
This invention provides an immunogenic composition including a soluble portion of a Mycoplasma hyopneumoniae (M.hyo) whole cell preparation, wherein the soluble portion of the M.hyo preparation is...
US20120093854 USE OF MYCOPLASMA BOVIS ANTIGEN  
The present invention relates to combination vaccines and/or the combined use of immunogenic compositions for the treatment and/or prophylaxis of cattle against microbiological infections, wherein...
US20140037716 IMMUNOGENIC COMPOSITION FOR IMMUNE SYSTEM MODULATION AND USE THEREOF, METHOD FOR TREATING AND PREVENTING DISEASES, METHOD FOR INDUCING CELL REGENERATION AND METHOD FOR RESTORING IMMUNE RESPONSE  
The present invention relates to immunogenic compositions for modulating the immune system, comprising a therapeutically effective quantity of two or more immuno-active antigenic agents with...
US20080181916 Canine Lyme Disease Vaccine  
The present invention provides a vaccine for canine Lyme disease and methods of making and using the vaccine alone, or in combinations with other protective agents.
US20090117152 Mycoplasma Hyopneumoniae Avirulent Adjuvanted Live Vaccine  
Provided are immunogenic and vaccine compositions and methods for their preparation and use, which compositions are effective in protecting against, minimizing the severity of, preventing, and/or...
US20080044440 Vaccine Formulated For Administration To Mucosa Of The Lungs  
There is disclosed vaccines formulated for administration to the mucosa of the lungs of a mammal, and the use thereof in methods for prophylaxis or treatment of an infection by at least one...
US20130064852 VACCINE AGAINST MYCOPLASMA, HYOPNEUMONIAE, SUITABLE FOR ADMINISTRATION IN THE PRESENCE OF MATERNALLY DERIVED ANTIBODIES  
The invention pertains to a vaccine comprising Mycoplasma hyopneumoniae antigens for intradermal application to an animal that has maternally derived antibodies directed against Mycoplasma...
US20140141041 RAPID AND PROLONGED IMMUNOLOGIC-THERAPEUTIC  
The present invention shows that intranasal administration of E1/E3-defective adenovirus particles may confer rapid and broad protection against viral and bacterial pathogens in a variety of...
US20090130148 MYCOPLASMA BOVIS VACCINE AND METHODS OF USE THEREOF  
The present invention relates to new attenuated M. bovis bacteria strains. Moreover, the present invention also provides immunogenic compositions comprising live bacteria of an of those attenuated...
US20140193457 IMMUNOSTIMULATORY OLIGODEOXYNUCLEOTIDES  
The present invention relates to immunostimulatory oligodeoxynucleotides, vectors and vaccines comprising such oligodeoxynucleotides, to their use as a medicament, to their use in preventing or...
US20090304737 Vaccine Against Mycoplasma PRRSV  
The present invention relates to the use of an immunogenic dose of immunogenic material of Mycoplasma hyopneumoniae and an immunogenic dose of live attenuated PRRS virus for the manufacture of a...
US20080193463 Mycoplasma Subunit Vaccine  
The present invention relates i.a. to vaccines for combating Mycoplasma infection, to mycoplasmal L-α-glycerophosphate oxidase for use in such vaccines, to the use of mycoplasmal...
US20080014221 Mycoplasma hyopneumoniae vaccine  
The invention provides a novel method of vaccination of a pig against Mycoplasma hyopneumoniae by administering to a weaned piglet or a sow, a single dose of an effective amount of a Mycoplasma...
US20140205633 IMMUNOSTIMULATORY OLIGODEOXYNUCLEOTIDES  
The present invention relates to immunostimulatory oligodeoxynucleotides, vectors and vaccines comprising such oligodeoxynucleotides, to their use as a medicament, to their use in preventing or...
US20150196634 CULTURED MYELOID DENDRITIC CELLS ISOLATED FROM PEYERS PATCHES AND USES THEREOF  
Cultured lysozyme-secreting myeloid dendritic cells isolated from the subepithelial dome of Peyer's patches in the small intestine are provided. The myeloid dendritic cells are used in screening...
US20110300179 Novel Compositions and Uses Thereof  
The present invention provides a cellular vaccine for therapeutic or prophylactic treatment of a pathological condition, the vaccine comprising or consisting of a population of CD 4+ T cells...
US20090068231 LIVE ATTENUATED MYCOPLASMA STRAINS  
The present invention provides live, attenuated Mycoplasma bacteria that exhibit reduced expression of one or more proteins selected from the group consisting of pyruvate dehydrogenase,...
US20090068232 ATTENUATED MYCOPLASMA GALLISEPTICUM STRAINS  
The present invention provides live, attenuated Mycoplasma gallisepticum bacteria that exhibit reduced expression of a protein identified as MGA_0621. In certain embodiments, the attenuated...
US20110104207 GYRASE INHIBITORS AND USES THEREOF  
The present invention relates to compounds which inhibit bacterial gyrase and pharmaceutically acceptable compositions comprising said compounds. These compounds, and compositions thereof, are...
US20080075694 MVA vaccine  
The present invention is directed to a recombinant MVA, which carries a nucleic acid sequence coding for a fusion protein. The present invention is further directed to a kit of parts containing...
US20080008718 Ornithobacterium Rhinotracheale Subunit Vaccines  
The present invention relates to nucleic acids encoding Ornithobacterium rhinotracheale proteins, to DNA fragments, recombinant DNA molecules, live recombinant carriers and host cells comprising...
US20160175418 Ureaplasma Vaccine and Antibodies  
The present invention encompasses methods and compositions for Ureaplasma infection prevention and/or treatment. In specific cases, the invention concerns vaccines for Ureaplasma, including DNA...
US20160082094 VACCINE TO PREVENT MYCOPLASMAL INFECTIONS IN WATERFOWL  
An improved vaccine for immunization of waterfowl such as ducks and geese comprises an inactivated strain of a mycoplasma infecting waterfowl, such as Mycoplasma sp. strain 1220; the vaccine can...

Matches 1 - 39 out of 39